DK513388D0 - Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2 - Google Patents
Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2Info
- Publication number
- DK513388D0 DK513388D0 DK513388A DK513388A DK513388D0 DK 513388 D0 DK513388 D0 DK 513388D0 DK 513388 A DK513388 A DK 513388A DK 513388 A DK513388 A DK 513388A DK 513388 D0 DK513388 D0 DK 513388D0
- Authority
- DK
- Denmark
- Prior art keywords
- peptides
- hiv
- viruses
- init
- antigen
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 241000713340 Human immunodeficiency virus 2 Species 0.000 title abstract 4
- 230000001900 immune effect Effects 0.000 title abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000031886 HIV Infections Diseases 0.000 abstract 3
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 2
- 102100021696 Syncytin-1 Human genes 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
- G01N2333/162—HIV-1, HIV-2 env, e.g. gp160, gp110/120, gp41, V3, peptid T, DC4-Binding site
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK200201277A DK175879B1 (da) | 1987-01-16 | 2002-08-30 | Nucleotidsekvenser, der koder for peptider med immunologiske egenskaber og rekombinante nucleinsyrer omfattende nucleotidsekvenserne |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US376487 | 1987-01-16 | ||
US07/003,764 US5051496A (en) | 1986-01-22 | 1987-01-16 | Peptides related to human immunodeficiency virus II (HIV-2) |
FR8701739A FR2610632B1 (fr) | 1987-02-11 | 1987-02-11 | Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida |
FR8701739 | 1987-02-11 | ||
FR8705398 | 1987-04-15 | ||
FR8705398A FR2614025B1 (fr) | 1987-04-15 | 1987-04-15 | Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida |
FR8800025 | 1988-01-05 | ||
PCT/FR1988/000025 WO1988005440A1 (fr) | 1987-01-16 | 1988-01-15 | Peptides ayant des proprietes immunologiques 2-hiv-2 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK513388D0 true DK513388D0 (da) | 1988-09-15 |
DK513388A DK513388A (da) | 1988-11-16 |
DK174705B1 DK174705B1 (da) | 2003-09-29 |
Family
ID=27251436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198805133A DK174705B1 (da) | 1987-01-16 | 1988-09-15 | Peptider med immunologiske egenskaber svarende til HIV-2 virus, antigene og immunogene midler indeholdende sådanne peptider samt fremgangsmåde og kit til en vitro diagnose af HIV-2 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0283327B1 (da) |
JP (5) | JP2948823B2 (da) |
AT (1) | ATE154808T1 (da) |
AU (1) | AU608294B2 (da) |
DE (1) | DE3855947T2 (da) |
DK (1) | DK174705B1 (da) |
ES (1) | ES2104556T3 (da) |
GR (1) | GR3024823T3 (da) |
WO (1) | WO1988005440A1 (da) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8701628D0 (sv) * | 1987-04-16 | 1987-04-16 | Erling Norrby | Medel for analys mm |
WO1989002277A2 (en) * | 1987-08-28 | 1989-03-23 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US5780038A (en) * | 1987-11-16 | 1998-07-14 | Roche Diagnostic Systems, Inc. | HIV-2 envelope polypeptides |
ATE87487T1 (de) * | 1987-11-16 | 1993-04-15 | Hoffmann La Roche | Rekombinante hiv-2 polypeptide. |
EP0327801A1 (en) * | 1988-01-08 | 1989-08-16 | Deutsches Primatenzentrum Gesellschaft Mbh | HIV-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions |
JP3093763B2 (ja) * | 1988-06-09 | 2000-10-03 | インスティチュート・パスツール | ヒトレトロウィルスhiv―2の外被糖タンパク質の前駆抗原及びそれと免疫学的同族性をもつ抗原、ならびにこれらの抗原の調製方法及び診断への応用 |
FR2632644B1 (fr) * | 1988-06-10 | 1994-11-04 | Pasteur Institut | Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic |
GB2220939B (en) * | 1988-06-10 | 1992-02-26 | Medical Res Council | Peptide fragments of hiv and their use in vaccines and diagnosis |
IL90553A0 (en) * | 1988-06-13 | 1990-01-18 | Us Health | Protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses |
FR2635532B1 (fr) * | 1988-07-29 | 1992-05-22 | Pasteur Institut | Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant |
EP0362927A3 (en) * | 1988-10-06 | 1990-11-14 | Akzo N.V. | Synthetic polypeptides immunochemically reactive with hiv antibodies |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
US5260189A (en) * | 1988-12-20 | 1993-11-09 | Immunodiagnostics, Inc. | Synthetic HIV-like peptides their compositions and uses |
FR2646854A1 (fr) * | 1989-05-12 | 1990-11-16 | Pasteur Institut | Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 antigenes presentant avec eux une parente immunologique |
ATE136789T1 (de) * | 1989-05-12 | 1996-05-15 | Pasteur Institut | Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene |
ES2083388T3 (es) * | 1989-05-31 | 1996-04-16 | Pasteur Institut | Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico. |
FR2647809B1 (fr) * | 1989-06-02 | 1991-09-20 | Pasteur Institut | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
CA2585164C (fr) * | 1989-06-02 | 2010-02-02 | Institut Pasteur | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour lediagnostic in vitro des infections dues a ces virus |
FR2647810B1 (fr) * | 1989-06-02 | 1994-07-22 | Pasteur Institut | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
US7022814B1 (en) | 1992-01-21 | 2006-04-04 | Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale | Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
DE3934366A1 (de) * | 1989-10-14 | 1991-04-18 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum |
US6248574B1 (en) * | 1989-12-13 | 2001-06-19 | Avigdor Shaffermann | Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
DE69129207T2 (de) * | 1990-01-16 | 1998-10-08 | Orgenics Ltd | Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS |
FR2657016B1 (fr) * | 1990-01-16 | 1995-08-25 | Clonatec Sa | Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida. |
DE4002636A1 (de) * | 1990-01-30 | 1991-08-01 | Boehringer Mannheim Gmbh | Expression von hiv1- und 2-polypeptiden und deren verwendung |
CA2109961A1 (en) * | 1991-06-03 | 1992-12-10 | Anders Vahlne | Peptides for use in induction of t cell activation against hiv-1 |
EP0726962B1 (en) | 1991-12-23 | 2006-06-07 | Chiron Corporation | Sets of HIV probes for use in solution phase sandwich hybridisation assays |
JPH0748276A (ja) * | 1992-03-26 | 1995-02-21 | Inmeru:Kk | Hiv感染症予防ワクチンおよびその製造法 |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
ATE467690T1 (de) * | 1997-08-01 | 2010-05-15 | Bio Rad Laboratories | Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern |
DE19908766C2 (de) * | 1999-02-19 | 2001-02-15 | Ulrich Schubert | Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien |
CA2562385A1 (en) * | 2004-04-09 | 2005-10-20 | University Of Manitoba | Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12 |
MX2007001916A (es) * | 2004-08-17 | 2007-07-11 | Ct Nat De La Rech Scentifique | Uso de la funci??n inmunosupresora de una prote??na auxiliar del virus de inmunodeficiencia humana o de simio para la preparaci??n de una vacuna. |
WO2007084021A2 (en) * | 2006-01-17 | 2007-07-26 | Instituto De Medicina Molecular | Compositions and methods for diagnosing hiv-2 infection |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE86636T1 (de) * | 1984-10-18 | 1993-03-15 | Pasteur Institut | F antigene vom menschlichen immunodefizienz-virus und deren verwendungen. |
AU600658B2 (en) * | 1984-12-24 | 1990-08-23 | Genentech Inc. | Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use |
DK171119B1 (da) * | 1985-04-19 | 1996-06-17 | Hoffmann La Roche | AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
DE3533440A1 (de) * | 1985-09-19 | 1987-03-26 | Hoechst Ag | N-substituierte 3,4,5,6-tetrahydrophthalimide, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz |
GR862412B (en) * | 1985-09-25 | 1987-01-23 | Oncogen | Vaccines and immuinoassays for acquired immune deficiency syndrome |
FR2593189B1 (fr) * | 1986-01-22 | 1989-10-20 | Pasteur Institut | Nouveau retrovirus susceptible de provoquer le sida, antigenes obtenus a partir de ce retrovirus et anticorps correspondants et leurs applications au diagnostic du sida |
EP0239425B1 (fr) * | 1986-01-22 | 1989-11-02 | Institut Pasteur | Rétrovirus du type HIV-2 susceptible de provoquer le SIDA, et ses constituants antigéniques et nucléiques |
EP0269520A3 (fr) * | 1986-11-21 | 1988-08-24 | Institut Pasteur | Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques |
JP3105581B2 (ja) * | 1991-07-03 | 2000-11-06 | 内橋エステック株式会社 | 面状温度ヒュ−ズ |
JPH0833969A (ja) * | 1994-07-22 | 1996-02-06 | Toyota Motor Corp | 加圧鋳造方法 |
-
1988
- 1988-01-15 AU AU12250/88A patent/AU608294B2/en not_active Expired
- 1988-01-15 ES ES88400084T patent/ES2104556T3/es not_active Expired - Lifetime
- 1988-01-15 DE DE3855947T patent/DE3855947T2/de not_active Expired - Lifetime
- 1988-01-15 AT AT88400084T patent/ATE154808T1/de not_active IP Right Cessation
- 1988-01-15 EP EP88400084A patent/EP0283327B1/fr not_active Expired - Lifetime
- 1988-01-15 JP JP63501472A patent/JP2948823B2/ja not_active Expired - Lifetime
- 1988-01-15 WO PCT/FR1988/000025 patent/WO1988005440A1/fr unknown
- 1988-09-15 DK DK198805133A patent/DK174705B1/da not_active IP Right Cessation
-
1995
- 1995-04-19 JP JP7117839A patent/JP2862810B2/ja not_active Expired - Lifetime
-
1997
- 1997-09-24 GR GR970402458T patent/GR3024823T3/el unknown
-
1999
- 1999-04-06 JP JP11099449A patent/JPH11322792A/ja active Pending
-
2001
- 2001-04-27 JP JP2001133477A patent/JP2002030099A/ja active Pending
-
2003
- 2003-05-19 JP JP2003140638A patent/JP2004002421A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU1225088A (en) | 1988-08-10 |
JP2004002421A (ja) | 2004-01-08 |
JP2862810B2 (ja) | 1999-03-03 |
ATE154808T1 (de) | 1997-07-15 |
DK513388A (da) | 1988-11-16 |
DK174705B1 (da) | 2003-09-29 |
EP0283327B1 (fr) | 1997-06-25 |
JPH01502119A (ja) | 1989-07-27 |
DE3855947D1 (de) | 1997-07-31 |
EP0283327A3 (fr) | 1989-01-04 |
JP2002030099A (ja) | 2002-01-29 |
AU608294B2 (en) | 1991-03-28 |
JP2948823B2 (ja) | 1999-09-13 |
GR3024823T3 (en) | 1998-01-30 |
EP0283327A2 (fr) | 1988-09-21 |
JPH11322792A (ja) | 1999-11-24 |
JPH07300498A (ja) | 1995-11-14 |
WO1988005440A1 (fr) | 1988-07-28 |
DE3855947T2 (de) | 1997-12-11 |
ES2104556T3 (es) | 1997-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK513388A (da) | Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2 | |
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
ES2061500T5 (es) | Diagnosis y vacunas de la hepatitis delta, su preparacion y uso. | |
DK33190A (da) | Hiv-3 retrovirus og anvendelse heraf | |
KR950032278A (ko) | 사람 면역결핍 바이러스 그룹의 레트로바이러스로부터 유래된 펩타이드 및 이의 용도 | |
ES2004133A6 (es) | Procedimiento para la preparacion de una nueva proteina. | |
DK11789A (da) | Rekombinante vaccinia-vira | |
ES2013346A6 (es) | Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles. | |
NO175153C (no) | Polypeptider | |
EP0293792A3 (en) | Human immunodeficiency virus gag-encoded proteins | |
EP0250128A3 (en) | Novel virus isolated from patients with aids | |
DK284389A (da) | Precursorantigener | |
ATE417108T1 (de) | Hiv-2 und siv-1 nukleotidsequenzen | |
PT86752A (pt) | Procede pour la preparation de peptides susceptibles d:etre reconnus par des anticorps induits contre des retrovirus d:immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et le cas echeant a la vaccination contre le sida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |